tosufloxacin has been researched along with temafloxacin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-March, FJ; Jaén-Oltra, J; Pérez-Giménez, F; Salabert-Salvador, MT; Tomás-Vert, F | 1 |
| Aubert, G; Dorche, G; Pozzetto, B | 3 |
| Bethune, L; King, A; Phillips, I | 1 |
| Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C | 1 |
| Jehl, F; Koechlin, C; Linger, L; Monteil, H | 1 |
| Barry, AL; Jones, RN | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Chin, NX; Neu, HC | 1 |
| Phillips, I; Power, EG | 1 |
11 other study(ies) available for tosufloxacin and temafloxacin
| Article | Year |
|---|---|
Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods.
Topics: Algorithms; Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Neural Networks, Computer; Structure-Activity Relationship | 2000 |
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1992 |
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
Topics: Anti-Infective Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1991 |
[In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; In Vitro Techniques; Naphthyridines; Pefloxacin; Quinolones; Streptococcus; Streptococcus agalactiae; Streptococcus bovis; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus sanguis | 1991 |
[In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterococcus faecalis; Fluoroquinolones; Imipenem; In Vitro Techniques; Naphthyridines; Piperacillin; Quinolones | 1991 |
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1990 |
High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids.
Topics: Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Humans; Molecular Structure; Naphthyridines; Quinolones; Spectrometry, Fluorescence | 1989 |
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Fluoroquinolones; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Quinolones | 1989 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activity of the new fluoroquinolone CP-99,219.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |